Page last updated: 2024-12-06

ritrosulfan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ritrosulfan: RN given refers to parent cpd(R*,S*)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID142773
CHEMBL ID3989812
SCHEMBL ID297132
MeSH IDM0040367

Synonyms (32)

Synonym
ritrosulfan
1,4-dideoxymesoerythritol
4148-16-7
nsc-122402
r 74 base
1,4-bis[(2-hydroxyethyl)amino]erythritol 1,4-dimethanesulfonate (ester)
1,4-di(mesyloxyethylamino)erythritol
3,15-dithia-6,11-diazahexadecane-8,9-diol, 2,2,15,15-tetraoxide, (r*,s*)-
erythritol,4-dideoxy-1,4-bis[(2-hydroxyethyl)amino]-, 1,4-dimethanesulfonate (ester), meso-
nsc122402
nsc 122402
1,4-(methylsulfonyloxyethylamino)-1,4-dideoxy-erythrioldimethylsulfonate
erythritol, 1,4-dideoxy-1,4-bis((2-hydroxyethyl)amino)-, 1,4-dimethanesulfonate (ester), meso-
1,4-bis(2'-mesyloxyethylamino)-1,4-dideoxy-meso-erythritol
ritrosulfano [inn-spanish]
erythro-5,6-dihydroxy-3,8-diazadecan-1,10-diyl bis(methansulfonat)
1,4-bis(2'-mesyloxyethylamino)-1,4-dideoxymesoerythritol
3,14-dioxa-2,15-dithia-6,11-diazahexadecane-8,9-diol, 2,2,15,15-tetraoxide, (r*,s*)-
ritrosulfanum [inn-latin]
ritrosulfan [inn]
3,14-dioxa-2,15-dithia-6,11-diazahexadecane-8,9-diol, 2,2,15,15-tetraoxide, (8r,9s)-rel-
1,4-dideoxy-1,4-bis((2-hydroxyethyl)amino)erythritol 1,4-dimethanesulfonate (ester)
2-[[(2s,3r)-2,3-dihydroxy-4-(2-methylsulfonyloxyethylamino)butyl]amino]ethyl methanesulfonate
ritrosulfano
unii-yiy0662kx9
yiy0662kx9 ,
ritrosulfanum
SCHEMBL297132
ritrosulfan [who-dd]
CHEMBL3989812
Q27294539
DTXSID801023469

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Treatment of cultures in each phase for 1 or 2 hrs resulted in threshold exponential type dose-response curves, yielding Do values of 3 and 1 microM, respectively."( Action of lycurim and pyrazofurin on hepatoma 3924A cells in culture.
Ban, J; Olah, E; Werber, G, 1982
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID409957Inhibition of bovine liver MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (95.24)18.7374
1990's0 (0.00)18.2507
2000's1 (4.76)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (9.09%)5.53%
Reviews1 (4.55%)6.00%
Case Studies1 (4.55%)4.05%
Observational0 (0.00%)0.25%
Other18 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]